Guyla G Johnson1, Misti C White1, Jian-He Wu1, Matthew Vallejo1, Maurizio Grimaldi1. 1. Laboratory of Neuropharmacology, Department of Biochemistry and Molecular Biology, Southern Research Institute, Birmingham, Alabama (G.G.J., M.C.W., J-H.W., M.G.); Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama (M.V.).
Abstract
BACKGROUND: The endoplasmic reticulum (ER) is involved in Ca(2+) signaling and protein processing. Accumulation of unfolded proteins following ER Ca(2+) depletion triggers the ER stress response (ERSR), which facilitates protein folding and removal of damaged proteins and can induce cell death. Unfolded proteins bind to chaperones, such as the glucose-regulated protein (GRP)78 and cause the release of GRP78-repressed proteins executing ERSR. METHODS: Several glioma cell lines and primary astrocytes were used to analyze ERSR using standard western blots, reverse transcription-PCR, viability assays, and single cell Ca(2+) imaging. RESULTS: ERSR induction with thapsigargin results in a more intense ERSR associated with a larger loss of ER Ca(2+), activation of ER-associated caspases (4/12) and caspase 3, and a higher rate of malignant glioma cell death than in normal glial cells. Malignant glioma cells have higher levels of protein synthesis and expression of the translocon (a component of the ribosomal complex, guiding protein entry in the ER), the activity of which is associated with the loss of ER Ca(2+). Our experiments confirm increased expression of the translocon in malignant glioma cells. In addition, blockade of the ribosome-translocon complex with agents differently affecting translocon Ca(2+) permeability causes opposite effects on ERSR deployment and death of malignant glioma cells. CONCLUSIONS: Excessive ER Ca(2+) loss due to translocon activity appears to be responsible for the enhancement of ERSR, leading to the death of glioma cells. The results reveal a characteristic of malignant glioma cells that could be exploited to develop new therapeutic strategies to treat incurable glial malignancies.
BACKGROUND: The endoplasmic reticulum (ER) is involved in Ca(2+) signaling and protein processing. Accumulation of unfolded proteins following ER Ca(2+) depletion triggers the ER stress response (ERSR), which facilitates protein folding and removal of damaged proteins and can induce cell death. Unfolded proteins bind to chaperones, such as the glucose-regulated protein (GRP)78 and cause the release of GRP78-repressed proteins executing ERSR. METHODS: Several glioma cell lines and primary astrocytes were used to analyze ERSR using standard western blots, reverse transcription-PCR, viability assays, and single cell Ca(2+) imaging. RESULTS: ERSR induction with thapsigargin results in a more intense ERSR associated with a larger loss of ER Ca(2+), activation of ER-associated caspases (4/12) and caspase 3, and a higher rate of malignant glioma cell death than in normal glial cells. Malignant glioma cells have higher levels of protein synthesis and expression of the translocon (a component of the ribosomal complex, guiding protein entry in the ER), the activity of which is associated with the loss of ER Ca(2+). Our experiments confirm increased expression of the translocon in malignant glioma cells. In addition, blockade of the ribosome-translocon complex with agents differently affecting translocon Ca(2+) permeability causes opposite effects on ERSR deployment and death of malignant glioma cells. CONCLUSIONS: Excessive ER Ca(2+) loss due to translocon activity appears to be responsible for the enhancement of ERSR, leading to the death of glioma cells. The results reveal a characteristic of malignant glioma cells that could be exploited to develop new therapeutic strategies to treat incurable glial malignancies.
Authors: Peter Pyrko; Adel Kardosh; Weijun Wang; Wenyong Xiong; Axel H Schönthal; Thomas C Chen Journal: Cancer Res Date: 2007-11-15 Impact factor: 12.701
Authors: Chen Chen Jiang; Li Hua Chen; Susan Gillespie; Yu Fang Wang; Kelly A Kiejda; Xu Dong Zhang; Peter Hersey Journal: Cancer Res Date: 2007-10-15 Impact factor: 12.701
Authors: Leen Verbert; Bora Lee; Sarah L Kocks; Zerihun Assefa; Jan B Parys; Ludwig Missiaen; Geert Callewaert; Rafael A Fissore; Humbert De Smedt; Geert Bultynck Journal: Biol Cell Date: 2008-01 Impact factor: 4.458
Authors: Adel Kardosh; Encouse B Golden; Peter Pyrko; Jasim Uddin; Florence M Hofman; Thomas C Chen; Stan G Louie; Nicos A Petasis; Axel H Schönthal Journal: Cancer Res Date: 2008-02-01 Impact factor: 12.701
Authors: Maria Pennuto; Elisa Tinelli; Mariachiara Malaguti; Ubaldo Del Carro; Maurizio D'Antonio; David Ron; Angelo Quattrini; M Laura Feltri; Lawrence Wrabetz Journal: Neuron Date: 2008-02-07 Impact factor: 17.173